Drug intelligence / Profile preview

Tuxil-D

Development stage
Unknown
Lead developer
Fidson HealthCare
Modality
Small Molecules
Administration
Oral
01

Overview

Tuxil-D is a combination pharmaceutical product developed and manufactured by Fidson Healthcare, primarily indicated for the symptomatic relief of cough and cold symptoms. It is formulated as an oral syrup containing three active ingredients: dextromethorphan hydrobromide, a cough suppressant that acts on the cough center in the brain; phenylephrine hydrochloride, a decongestant that shrinks swollen nasal mucous membranes; and chlorpheniramine maleate, an antihistamine that reduces allergic symptoms like sneezing and runny nose. The product is widely marketed in West Africa as an over-the-counter (OTC) or prescription-branded generic for upper respiratory tract infections and allergic rhinitis.

Brand names
Tuxil-D
Other names
Tuxil D
02

Targets

TRPM8 (Transient receptor potential cation channel subfamily M member 8)ADRB2 (β2)HRH1 (Histamine H1 Receptor)ADRA1A (α1A)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on Tuxil-D.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tuxil-D.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call